Faculty Opinions recommendation of Bl-1020, a new γ-aminobutyric acid-enhanced antipsychotic: results of 6-week, randomized, double-blind, controlled, efficacy and safety study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717962039.793466255 ◽

2012 ◽

Author(s):

John Davis

Keyword(s):

Aminobutyric Acid ◽

Efficacy And Safety ◽

Safety Study ◽

Download Full-text

Faculty Opinions recommendation of A Randomized, Double-Blind, Active- and Placebo-Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726225272.793528705 ◽

2017 ◽

Author(s):

Michael Pillinger

Keyword(s):

Efficacy And Safety ◽

Safety Study ◽

Download Full-text

A Comparison of Tiotropium 18µg, Once Daily and Ipratropium 40µg, 4 Times Daily in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults with Chronic Obstructive Pulmonary Disease

Tuberculosis and Respiratory Diseases ◽

10.4046/trd.2005.58.5.498 ◽

2005 ◽

Vol 58 (5) ◽

pp. 498 ◽

Author(s):

Seung Joon Kim ◽

Myung Sook Kim ◽

Sang Haak Lee ◽

Young Kyoon Kim ◽

Hwa Sik Moon ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Download Full-text

One‐Year Efficacy and Safety Study of a 1.62% Testosterone Gel in Hypogonadal Men: Results of a 182‐Day Open‐Label Extension of a 6‐Month Double‐Blind Study

Journal of Sexual Medicine ◽

10.1111/j.1743-6109.2011.02630.x ◽

2012 ◽

Vol 9 (4) ◽

pp. 1149-1161 ◽

Author(s):

Joel M. Kaufman ◽

Michael G. Miller ◽

Sherahe Fitzpatrick ◽

Cecilia McWhirter ◽

John J. Brennan

Keyword(s):

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Testosterone Gel ◽

Open Label Extension ◽

Download Full-text

Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)]

Neurocritical Care ◽

10.1007/s12028-018-0575-z ◽

2018 ◽

Vol 30 (1) ◽

pp. 88-97 ◽

Author(s):

Daniel Hänggi ◽

◽

Nima Etminan ◽

Stephan A. Mayer ◽

E. Francois Aldrich ◽

...

Keyword(s):

Subarachnoid Hemorrhage ◽

Aneurysmal Subarachnoid Hemorrhage ◽

Standard Of Care ◽

Efficacy And Safety ◽

Safety Study ◽

Phase 3 ◽

Double Blind ◽

Group Efficacy ◽

Double Blind Placebo ◽

Download Full-text

A double-blind efficacy and safety study of sertraline and clomipramine in severe major depression

Biological Psychiatry ◽

10.1016/s0006-3223(97)87943-7 ◽

1997 ◽

Vol 42 (1) ◽

pp. 249S ◽

Author(s):

J.P. Lépine ◽

R.L. Wiseman ◽

G. Zhu

Keyword(s):

Major Depression ◽

Efficacy And Safety ◽

Safety Study ◽

Download Full-text

EGFR Mutant Subset Analysis From Archer 1009: a Randomized Double Blind Phase 3 Efficacy and Safety Study of Dacomitinib Versus Erlotinib for the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)

Annals of Oncology ◽

10.1093/annonc/mdv050.02 ◽

2015 ◽

Vol 26 ◽

pp. i29

Author(s):

L. Paz-Ares ◽

K. O'Byrne ◽

T.S.K. Mok ◽

M. Boyer ◽

P.A. Jänne ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Safety Study ◽

Phase 3 ◽

Double Blind ◽

Download Full-text

The efficacy and safety study of dietary supplement PURIAM110 on non-insulin taking Korean adults in the stage of pre-diabetes and diabetes mellitus: protocol for a randomized, double-blind, placebo-controlled, and multicenter trial-pilot study

Trials ◽

10.1186/1745-6215-12-38 ◽

2011 ◽

Vol 12 (1) ◽

Author(s):

Sunju Park ◽

Jeong-Su Park ◽

Hoyeon Go ◽

Bo-Hyoung Jang ◽

Yongcheol Shin ◽

...

Keyword(s):

Diabetes Mellitus ◽

Pilot Study ◽

Dietary Supplement ◽

Multicenter Trial ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study

Clinical Therapeutics ◽

10.1016/j.clinthera.2008.04.002 ◽

2008 ◽

Vol 30 (4) ◽

pp. 587-604 ◽

Author(s):

Steven G. Chrysant ◽

Michael Melino ◽

Sulekha Karki ◽

James Lee ◽

Reinilde Heyrman

Keyword(s):

Blood Pressure ◽

High Blood Pressure ◽

Olmesartan Medoxomil ◽

Efficacy And Safety ◽

Amlodipine Besylate ◽

Safety Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Romosozumab in Postmenopausal Korean Women with Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study

Endocrinology and Metabolism ◽

10.3803/enm.2020.848 ◽

2021 ◽

Vol 36 (1) ◽

pp. 60-69

Author(s):

Ki-Hyun Baek ◽

Yoon-Sok Chung ◽

Jung-Min Koh ◽

In Joo Kim ◽

Kyoung Min Kim ◽

...

Keyword(s):

Korean Women ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A Randomized, Double-Blind, Efficacy and Safety Study of PF-05280586 (a Rituximab Biosimilar) Compared with Rituximab Reference Product (MabThera®) in Subjects with Previously Untreated CD20-Positive, Low-Tumor-Burden Follicular Lymphoma (LTB-FL)

BioDrugs ◽

10.1007/s40259-019-00398-7 ◽

2019 ◽

Vol 34 (2) ◽

pp. 171-181 ◽

Author(s):

Jeff P. Sharman ◽

Anna Marina Liberati ◽

Kenichi Ishizawa ◽

Tahira Khan ◽

Jeffery Robbins ◽

...

Keyword(s):

Follicular Lymphoma ◽

Reference Product ◽

Tumor Burden ◽

Efficacy And Safety ◽

Safety Study ◽

Download Full-text